Find news and press releases on SHRO discoveries, events, and other significant announcements.


PRESS RELEASES: 2011- 2005


New Adiponectin Compound Developed

November 14, 2011

A compound that mimics the effects of adiponectin, a beneficial protein that is produced by fat tissue in healthy weight individuals and may exhibit protective effects against cancer, cardiovascular disease, inflammatory conditions and insulin resistance has been developed by an international consortium lead by Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University’s College of Science and Technology.

New Frontiers: An International Workshop Examining the Latest Research in Cancer Prevention

November 2, 2011

November 2 special public policy medical conference New Frontiers: An International Workshop Examining the Latest Research in Cancer Prevention sponsored by the Sbarro Health Research Organization and the National Italian American Foundation, was held on October 28th during  the NIAF 36th Anniversary Gala Convention.

FDA Delays Approval of New Diabetes Drug

October 27, 2011

The Food and Drug Administration announced that they are pushing back its decision date to approve dapagliflozen, an experimental once-a-day drug to treat adults with Type 2 diabetes from AstraZeneca and Bristol-Myers Squibb, Bloomberg Business Week reports.

Second Annual Giovan Giacomo Giordano Award for Ethics and Creativity in Medical Research

October 29, 2011

Dr. George Katter, a cardiologist who has dedicated a large part of his career to serving the sick and the poor  Western Pennsylvania and in Haiti,  will receive  the second annual Giovan Giacomo Giordano Foundation and the National Italian American Foundation Award for Ethics and Creativity in Medical Research. Dr. Katter will be recognized at  the National Italian American Foundations' 36th Anniversary Awards Convention Weekend, held October 28-29 at the Washington Hilton in Washington, D.C. Dr. Antonio Giordano, NIAF board member and President and Founder of the Sbarro Health Research Organization, will present the award.

SHRO Featured in  Seminar on U.S. & Italian Strategies for   Turning Academic Research into Business

October 5, 2011

The Sbarro Health Research Organization will be featured in a U.S. and Italian Research Start Up Showcase during   U.S. & Italian Strategies for Turning Academic Research into Business -- An Italian Trade  Commission International Seminar to Support U.S. -Italy Technology Transfer. The seminar will be held at the Cambridge Innovation Center on October 13-14th. Dr. Giuseppe Russo, research assistant professor and Director, Cancer Systems Biology and e-Health Programs for SHRO, will present SHRO as a case study of a successful international start up.

Cancer Costs Soar

October 3, 2011

Cancer costs are rising at such a rapid rate that they threaten to become unsustainable even for rich countries, according to an expert panel assembled the The Lancet Oncology medical journal and reported by Bloomberg News.

Congress to Focus on Body, Mind and Health

September 27, 2011

Sbarro Health Research Organization and the Philadelphia and Delaware Valley branch of the Dominican Medical Collegiate will sponsor the 11th Dominican-American Medical Congress on the theme of Body, Mind and Health  on September 30-October 2 at the Holiday Inn Hotel in Breinigsville, PA. The event will include a gala dinner and tours to historical sites in the Allentown area. For more information, call 215-291-9392 or 215-229-4357 or go to

Study Suggests Higher Cancer Risk for 9/11 Firefighters

September 10, 2011

A new study shows that firefighters who worked in the wreckage of the World Trade Center were 19 percent more likely to develop cancer than those who were not there, reports the New York Times. The study, which is the strongest evidence to date of a possible link between work at ground zero and cancer, was published in The Lancet.

A Look at Systems Biology

September 1, 2011

Grad student David Mangani Rizzo defines Systems Biology

Vatican Archbishop Visits Sbarro Health Research Organization

August 11, 2011

Sbarro Health Research Organization Biotechnology Research Center welcomed Archbishop Zygmunt Zimowki, the president for the Pontifical Council for Pastoral Care of Health Care Workers for the Catholic Church at the Vatican. Monsignor Zimowki is in charge of the church's global outreach for equitable health care.

The Catholic Standard & Times

New Avenues Open Up for Mesothelioma Therapies

July 25, 2011

Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors.  Results appear in the journal Oncogene.

Salerno, Italy Honors Dr. Giordano

July 25, 2011

Congratulations to Antonio Giordano, M.D., PhD, the Director of the Sbarro Health Institute for Cancer Research and Molecular Medicine in Philadelphia, who on July 23rd received the prestigious Premio Salernitani illustri nel mondo prize for his professional contributions. The award was presented at the Palace St. Augustine in Salerno, Italy

GRTV (in Italian)

Toxic Waste Dumps in Campania Region Exacts High Toll on Residents' Health

July 7, 2011

A new report from the Sbarro Institute and the Human Health Foundation shows mounting scientific evidence that supports a significant increase in cancer mortality and malformations in specific areas of the Campania Region of Southern Italy, where improper waste management and illegal waste trafficking have been repeatedly documented. The  study, Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy , was published in Cancer Biology & Therapy.


The Independent

Dangers of Non-Filtered Cigarettes

June 27, 2011

While many young people mistakenly believe that hand-rolled cigarettes are less dangerous to smoke than filtered cigarettes, a new study shows that smoking hand-rolled cigarettes has stronger genotoxic and oxidative effects on the metabolism than smoking manufactured filtered-cigarettes.

Mutation Research

Entering the "Genomic Era" in Cancer Care

June 27, 2011

Cancer treatment is on the brink of a new era of genome based treatment, according to Dr. George Sledge, the outgoing president of ASCO. And the Sbarro Health Research Organization for Biotechnology Research is on the cutting edge of this revolution in genomic therapies.

Important New Skin Cancer Drug Approved

June 16, 2011

Michele Maio, a member of the scientific board of the Sbarro Health Research Organization (SHRO) and  director of the Center for Cancer Immunotherapy of Siena, in collaboration with researchers from Human Health Onlus Foundation (HHF) of Spoleto, led the project Nibit M1, using for the first time Ipilimumab in combination with a chemotherapeutic agent (fotemustine) to combat cancer.  Ipilimumab has recently been approved by the FDA for the treatment of skin cancer.


Life Sciences Cited as Economic Driver

May 27, 2011

University City Science Center President & CEO Stephen S. Tang, Ph.D., MBA, highlighted the importance of the life sciences as an economic driver as he testified at a hearing of the U.S. Congress Joint Economic Committee on Wednesday, May 25, 2011 in Washington, DC.

Current Clinical Pathology

May 17, 2011

Humana Press link for Current Clinical Pathology Series, edited by Antonio Giordano, M.D., Ph.D.   This series includes monographs dealing with important topics in surgical pathology, cytopathology hematology, and diagnostic laboratory medicine. It is aimed at practicing hospital based pathologists and their residents providing them with concise up-to- date reviews and state of the art summaries of current problems that these physicians may encounter in their daily practice of clinical pathology.

Long Lasting Insulin Tested

May 2, 2011

New long lasting insulin  degludec may cut down on doses  for Type-2 diabetics.

The Lancet

Rep. Critz Tours SHRO Research Facility

April 19, 2011

United States Congressman Mark S. Critz (D-PA) visited the Sbarro Health Research Organization for Biotechnology at the College of Science and Technology on the campus of Temple University. Expressing his strong support for funding biotechnology research, Rep. Critz toured the newly renovated SHRO facility with Dr. Antonio Giordano, the President and Founder of SHRO and the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Dr. Hai-Lung Dai, the Dean of the College of Science and Technology.

Study Highlights Cancer Fighting Properties of Good Nutrition

April 19, 2011

A new study sponsored by the  Human Health Foundation and led by Umberto Galderisi, Associate Professor at the Department of Experimental Medicine, Second University of Naples and an adjunct professor at the Sbarro Institute in Philadelphia, USA, highlights the quality of certain vegetables, especially broccoli, in preserving the 'vitality' of stem cells.

Clinical trial success for Crohn's disease cell therapy

April 13, 2011

Professor Miguel Forte described research into a new cell therapy for chronic inflammatory conditions such as Crohn's disease. Patient's own blood cells are used to produce a type of cell, Type 1 T regulatory lymphocyte,that can reduce the extent of the disease.


Antonio Giordano, M.D., Ph.D. Named to NIAF Board

March 28, 2011

President and Founder of S.H.R.O  is one of seven prestigious Italian-Americans, who have excelled in the fields of communication, business and medicine, to be elected to the Board of Directors of the National Italian American Foundation (NIAF).

A Miserable Life May Lead to Longevity

March 5, 2011

A new study upends common beliefs about what makes for a long life.

Two Proteins Play Key Roles in Burkitt's Lymphoma

March 4, 2011

A new study from the Sbarro Health Research Organization reveals new molecular insights into the understanding and treatment of Burkitt`s lymphoma.

Cell Cycle

New Study Finds Molecular Mechanisms that Control Rb2/p130 Gene Expression in Lung Cancer

February 24, 2011

New findings from SHRO reveal why the  Rb2/p130 gene is expressed differently in small and non-small lung cancer cells.


Scientists Under Pressure

February 16, 2011

Do we expect scientists always to be right? And have these expectations, along with a need to publish and be funded, led to an epidemic of problems with medical research?  An insightful article, Lies, Damned Lies, and Medical Science  examines these pressing issues.

Proposed NIH Budget Cuts Go Deep

February 9, 2011

House Appropriations Chairman Hal Rogers announced a partial list of 70 spending cuts that will be included in an upcoming Continuing Resolution (CR) Bill that covers the remainder of government spending for fiscal year (FY) 2011.
Cuts include a $1 billion cut in the National Institutes of Health, which will result in a freeze at the FY 2010 level.

Cell Cycle Regulators/Inhibitors & Cancer

January 12, 2011

International Conference, Feb. 5-8, 2011, Vienna

For more information go toCnference


SHRO Supports The Lancet's Case Against Canadian Asbestos

December 10, 2010

Dr. Antonio Giordano, the director of the Sbarro Institute for Cancer Research and Molecular Medicine and Chairman of the Scientific Advisory Committee for the Human Health Foundation, a nonprofit biomedical research foundation in Italy, has voiced deep concerns about the actions of the Canadian government for its support of the asbestos industry.
"There is no doubt that asbestos causes cancer," said Dr. Giordano. "The actions of the Canadian government in supporting the continued development and exportation of asbestos are immoral and unsupportable."
Dr. Giordano's comments arise in response to a new article published in The Lancet, the prestigious British medical journal, that accuses Canada of hypocrisy over asbestos exports, noting that while Canada is pulling asbestos out of its buildings, it still exports the cancer-causing product to less wealthy countries.

Dr. Giordano Awarded Honorary Professorship

December 7, 2010

The Autonomous University of Santo Domingo (UASD) has named Dr. Antonio Giordano, the Director of the Sbarro Institute for Cancer Research and Molecular Medicine, as an Honorary Professor in the Faculty of Health Sciences for his valuable contributions to research and the development of biomedicine.

Single Shot of Morphine Shows Long Lasting Effect on Testosterone Levels

November 9, 2010

A single injection of morphine to fight persistent pain in male rats strongly reduces the hormone testosterone in the brain and plasma, according to a new paper published in Molecular Pain. The study was led by Anna Maria Aloisi, M.D., of the Department of Physiology – Section of Neuroscience and Applied Physiology at the University of Siena, Italy, in collaboration with the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the University of Siena, and the Human Health Foundation in Spoleto, Italy.

Medical News Today

Inaugural Award for Ethics and Medical Creativity

October 20, 2010

On October 22nd, the Giovan Giacomo Giordano Foundation and the National Italian American Foundation (NIAF)( will jointly present the first Award for Ethics and Medical Creativity to Senator Prof. Ignazio R. Marino at the NIAF 35th anniversary gala at the Washington Hilton in Washington, D.C.The award honors the memory of Prof. Giovan Giacomo Giordano, a distinguished Italian medical oncologist and pathologist who devoted over 60 years of his life to the fields of cancer research and teaching.

Metabolic syndrome affects breast cancer  risk in  postmenopausal women

October 18, 2010

Metabolic syndrome may be an indicator of breast cancer risk in post-menopausal women, according to a new study published by CROM (The Cancer Research Center in Mercogliano, Italy), the National Cancer Institute of Naples, Italy, and the Sbarro Health Research Organization, located at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy. Lead authors of the study were Immacolata Capasso, M.D. and Emanuela Esposito, M.D. both of the Department of Senology at the National Institute of Naples and Antonio Giordano, M.D., Ph.D., Director of the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA. Results of the study are online and will be published in the December issue of Cancer Biology and Therapy.

Let's Talk About It! A Panel Discussion on Breast Cancer Awareness

October 9, 2010

Join NIAF and the Sbarro Health Research Organization for a panel discussion on breast cancer on October 22nd  during the 35th Gala of the National Italian American Foundation. Panelists include Dr. Antonio Giordano, Director of the Sbarro Institute for Molecular Medicine and Center for Biotechnology; Dr. Silvia Formenti, Chairman, NYU Dept. of Radiology;  and Sen, Ignazio Marino, Investigative Committee on the National Healthcare System(Italian Senate).

Breaking Ground for SHRO Wing for International Students and Researchers

October 5, 2010

On Friday, October 1, groundbreaking ceremonies were held for the new Beech International Apartments at Temple University, which will house the Sbarro Health Research Organization wing for international students and researchers.

Prestigious Award to Antonio Giordano

October 4, 2010

Antonio Giordano, M.D., Ph.D., Director of the Sbarro  Institute for Cancer Research and  Molecular Medicine and the Center for Biotechnology, was awarded the title of Commendatore, or Knight Commander, by the Republic of Italy on October 1st. The award was given for his important findings in cancer research. The awards are bestowed on "exemplary citizens who have shown respect for civic values and their work in the interest of common development.

New Research Holds Promise for Treating Breast Cancer

September 26, 2010

Leptin may reduce the cytotoxicity of cAMP elevating agents and lead to new treatments for breast cancer. An interview with Dr. Silvio Naviglio of the Second University of Naples.

Journal of Cell Physiology

Promising New BioTherapy Against Melanoma

September 16, 2010

SHRO Scientific Advisory Board Member Michele Maio announces trials for promising new cancer treatment

Top 20 Papers in Molecular Cancer -- SHRO Paper Makes the List

September 7, 2010

R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair

PubMed     Molecular Cancer

Heart Attacks Jump in Young Italian Women

August 31, 2010

The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation (HHF), a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy.

Aging Clinical Experimental Research     Eureka Alert

SHRO Researchers Interviewed on Fast Breaking paper by

August 19, 2010

Cover Article on Cell Cycle Kinases by Silvia Lapenna & Antonio Giordano Draws High Citations and Recognition from Thomson-Reuters

'Big Ride' in Philly Benefits SHRO

August 10, 2010

The Philadelphia Inquirer

Who Controls Tumor Tissues?

August 2, 2010

Hospitals and patients wrestle over tumor tissue procurement, reports The Philadelphia Inquirer.

Increases in Leptin May Promote Colorectal Cancer

July 19, 2010

A Sbarro Institute and Istituto Superiore di Sanita, Rome, Italy study published in Endrocrine-Related Cancer  shows that an increase in leptin, a cytokine that is normally increased in obese or overweight individuals, may promote colorectal neoplasms by activating colorectal cancer stem cells.

Medical News Today

FDA Approves Butrans for Pain

July 2, 2010

Lifetime of Achievement Award Given to Dr. Giulio Tarro

June 21, 2010

Distinguished clinician-researcher honored by SHRO for discoveries and service to community.

New Human Health Foundation Lab Opens

June 7, 2010

The Human Health Foundation (HHF), a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy opened its first bioscience laboratory for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy.

Provenge Approved for Advanced Prostate Cancer

May 30, 2010

The U.S. Food and Drug Administration has approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.

Understanding the Pathways to Cancer

May 30, 2010

The complex mechanisms and pathways behind genetic and epigenetic changes underpin the work of Marcella Macaluso, Ph.D., a research associate professor and Director of the Genetics & Epigenetics Program at the Sbarro Health Research Organization Center for Biotechnology

Sbarro Institute Joins Conference on HPV

May 25, 2010

Naples conference to discuss prevention of HPV-related diseases

Understanding Fat

April 27, 2010

Eva Surmacz, Ph.D., associate professor in Biology at Temple University and the Director of the Obesity and Cancer Program at SHRO studies how the cytokine leptin can cause cancer and interfere with anti-cancer therapies.

Study: High fat Diet  Ups Strokes in Postmenopausal Women

April 27, 2010

Post-menopausal women who consume the most daily dietary fat had a 40 percent higher incidence of strokes compared with women who ate the least amount, according to research presented at the American Stroke Association International Stroke Conference 2010.

New Pyrimidine Compounds May Lead to Improved Treatments for Childhood Brain Cancer

April 7, 2010

Src represents one of the most promising targets for cancer therapy. A new study by researchers from the Sbarro Health Research Center for Biotechnology  and the Human Health Foundation (, shows that pyrazolo-[3,4-d]–pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma, a childhood brain cancer. The results were published in FASEB (The Journal of the Federation of American Societies for Experimental Biology).

FASEB (abstract)

Eureka Alert


Let's Combat Pain

March 22, 2010

New online forum puts pain treatment in the spotlight.

Novel Researcher: Luca D'Agostino

March 22, 2010

Investigating Novel Structure Proteins (NSPs) to  locate new targets for cancer therapies

Cutting Gravity May Speed Healing

February 18, 2010

Altering gravitational forces may speed the growth and repair of tissues at the cellular level, according to research completed by Andrew Puca, Ph.D., of the Sbarro Health Research Organization Center for Biotechnology Research.

Can Virtual Reality Help You to Shed Pounds?

February 17, 2010

A new study funded by the College of Health Professions and Social Work Interdisciplinary Research Fund at Temple University will pair the biotechnology skills of Dr. Giuseppe Russo, a research assistant professor and director of e-Health and Cancer Systems Biology programs at the Sbarro Health Research Organization Center for Biotechnology Research in the College of Science & Technology and the weight loss expertise of Dr. Melissa Napolitano, an associate professor at the Center for Obesity Research and Education (CORE) and Departments of Kinesiology and Public Health to find out.

Chronic Dry Eyes Can Be Helped

February 5, 2010

Dr. Mina Massaro-Giordano, an associate professor at the University of Pennsylvania and co-director of the Penn Dry Eye & Ocular Center, explains the problem of dry eyes and the newest therapies..

NBC Video

Why do Stem Cells Age? New study sheds light on senescence process

January 22, 2010

Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the Human Health Foundation in Spoleto, Italy have found that MECP2, a gene that modifies the chromatin in the cell, has important role in stem cell aging.


Changes in tumor suppressor gene suggest a heritable susceptibility to retinoblastoma

January 20, 2010

Researchers working at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have found that the downregulation, or reduction, of the tumor suppressor gene 16INK4A may be a novel marker of the heritable susceptibility for the disease.  The study  appears in the  Journal of Cellular Physiology.

Medical News Today

January is Glaucoma Awareness Month: Have You Scheduled an Eye Exam?

January 20, 2010

Glaucoma, a group of eye diseases that damage the optic nerve and destroy eyesight, affects close to four million Americans, although half are not aware that they have it. Worldwide, the World Health Organization reports that glaucoma is the primary cause of blindness for about 4.5 million people With its painless and gradual loss of vision, glaucoma may have no early warning signs, but it can be detected during a comprehensive dilated eye exam.


Tracking the H1NI Pandemic in Italy

November 20, 2009

According to the Italian news agency ANSA, as of November 19th, 75 Italians have died from H1N1, with 28 from the Campania region of Naples.Giulio Tarro, M.D., the Chief Physician of Virology at Cotugno Hospital of Naples and an adjunct professor at Temple University of Philadelphia  discusses the impact, treatment and future of the flu  epidemic.

SHRO Research on Stem Cells Recognized

November 20, 2009

Research by Umberto Galderisi and Antonio Giordano on the effect of stem cells in the treatment of arterial stenosis will be published as part of the proceedings of the prestigious 5th International Conference on Mesenchymal and Non-Hematopoietic Stem Cells (MSCs) at Texas A & M Health Science Center College of Medicine.


Antonio Giordano Receives Dean's Distinguished Award for Excellence in Research

November 15, 2009
Antonio Giordano, the President of the Sbarro Health Research Organization, Inc., the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology has won the Dean's Distinguished Award for Excellence in Research.

The award cites the quality of his work, "attested to by the fact that it provides an impetus for other investigators studying cancer growth control and it has resulted in a framework for our conceptualization of cancer development and mechanisms of tumor suppression."


Ang Sun, Ph.D. Wins Prize for 'Outstanding Research'

November 3, 2009

Dr. Ang Sun, who studied for six years for his Ph.D. under the guidance of Antonio Giordano, M.D., Ph.D., the Founder and President of the Sbarro Health Research Organization, has been awarded the 2009 Award for Outstanding Research by a Graduate Student from the College of Science and Technology at Temple University.

Sbarro Health Research Organization Welcomes New Biotech Research Center

October 27, 2009

The Sbarro Health Research Organization, a nonprofit research facility located at Temple University, dedicated a new state-of-the-art biotechnology research center on October 27th. SHRO has been ranked as one of the top three international laboratories based on number of publications as ranked by the Cell Cycle Registry.

Temple Times online
Philadelphia Business Journal


Dedication Planned for New SHRO Biotechnology Research Center

October 18, 2009

The Sbarro Health Research Organization,will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m.

A host of dignitaries will join guests and researchers at the dedication ceremony, including Pennsylvania Representatives the Honorable Sam Smith and Mario J. Civera , Jr.  Also in attendance will be His  Eminence Cardinal Justin Rigali, Archbishop of Philadelphia, Ann Weaver Hart, the President of Temple University, and Hai-Lung Dai, Ph.D., the Dean of Temple University’s College of Science and Technology.

Cold Spring Harbor Laboratory  Celebrates Another Nobel Laureate

October 5, 2009

CSHL graduate Antonio Giordano remembers Carol Greider, 2009 Nobel Prize Winner in Medicine.


"National Mesothelioma Awareness Day" Introduced in Congress

October 2, 2009

Few Americans know the truth about mesothelioma, a deadly and incurable cancer cauesd by exposure to asbestos. Heavy and widespread use of asbestos through most of the last century, coupled with a 20-50 year latency in tumor development, make mesothelioma today a lethal threat to tens of millions of Americans. Yet, the U.S. has ignored the need for research to develop effective treaments, and   still has not even banned asbestos.

Antonio Giordano and SHRO Model Profiled in  Canadian Newspaper: Corriere Canadese

September 27, 2009

Antonio Giordano Wins Philip Mazzei 'The Bridge ' Award

September 24, 2009

President and Founder of SHRO  receives the prestigious   prize from The American University of Rome, in  recognition of his work to promote economic and scientific cooperation between Italy and the United States.



August 28, 2009

Bidding starts at $25,000  (it's tax-deductible!) to get Your Name (or  your loved one's or your company's) on  a   fellowship to be   awarded by the Philadelphia and Siena Italy-based Sbarro Health Research Organization.  Place your bid on E-Bay by clickin here !

Summer Brings High School Interns to the Sbarro  Institute

August 18, 2009

If it is summer in the city, that means that high school interns are hard at work in the Sbarro Institute laboratories located at Temple University in Philadelphia. This year, the Institute hosted three high school juniors, who worked closely with Sbarro Institute post-doctorate fellows Marco Cassone, M.D., Ph.D. and Valentina Caracciolo, Ph.D. and Annalisa Roberti, a Ph.D student.

Antonio Giordano, M.D., Ph.D.: A War We Must Win
August 11, 2009
In an impassioned Op-ed that appeared in the August 5th edition of the New York Times, Nobel Laureate James Watson called for a second "war on cancer" to finance and ease the regulatory path towards the development of new cancer drugs. Antonio Giordano, the President and Founder of S.H.R.O, writes that we must support Watson's call.

Neuronal Guidance Molecule May Lead to Future Treatments for Human Embryonal Carcinoma
August 1, 2009
A new finding shows that Netrin-1, a neuronal guidance molecule, may play a critical role in reducing the aggressiveness of human embryonal carcinoma (EC) cells. Results of the study appear in the journal Cancer Research.

Students Visit SHROs Digilab:
July 15, 2009
Researchers around Temple University’s Campus have welcomed BITS participants into their research centers, study zones, and smart classrooms as part of a six-week summer intensive program to learn sophisticated information and communication technology skills and applications. Next week, BITS students will visit the Digilab, a center for using virtual realities to support e-health research.

Cell Cycle Kinases as Therapeutic Targets for Cancer:
July 3, 2009
A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery written by Antonio Giordano, M.D., Ph.D.,  DIrector of the Sbarro Institute for Cancer Research and Molecular Medicine, Director of the Center for Biotechnology at Temple University in Philadelphia, PA and ‘Chiara fama’ Professor in the Department of Pathology & Oncology at the University of Siena in Siena, Italy and Silvia Lapenna, Ph.D., a member of CROM (Center for Oncology Research) in Mercogliano, Italy, forecasts that "novel compunds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical  evaluation."
Medical News Today

Antonio Giordano, M.D., Ph.D. Places Third on  List of "Laboratory Heads by Number of Publications"
Cell Cycle Registry: July 2, 2009


Rate of Breast Cancer in Italy Significantly Higher  Than Previously Reported: June 29, 2009
A new analysis of breast cancer in Italy  from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick  of +28.6 percent found in the youngest group studied (ages 25 to 44). Results from the Sbarro Health Research Organization, the CROM (Centro Richerhe Oncologiche Mercogliano) in Mercogliano, Italy, and the Human Health Foundation appear in The Journal of Experimental & Clinical Cancer Research.
Breast Cancer News (access by subscription only)

Italy Welcomes New Public Health TV Channel
On February 1st, Italian television introduced a new channel devoted to wellness, disease prevention, and nutrition. Salute!, which appears on Sky Television, is the first channel of its kind in Italy.

Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation, the Sbarro Institute for Cancer Research and Molecular Medicine, report in Stem Cells and Development. The study represents a joint international effort between the Sbarro Health Research Organization, in Philadelphia, PA, Che University of Siena, in Siena, Italy and Bambin Gesu' in Rome, Italy.

Gene Marker May Improve Odds on Stem Cell Therapies for Disease
Researchers have tagged two new potential targets for treating rhabdomyosarcoma (RMS) -- a highly malignant pediatric tumor thought to arise from mesenchymal stem cells (MSCs) committed to become skeletal muscle cells. The report appears in Cell Cycle.

With an Eye To Italy
Sbarro Health Research Organization President, Antonio Giordano, M.D., featured in Philadelphia Inquirer: With an Eye to Italy: Research scientist builds lab and lures fine minds from home.


International Conference Hosts Digi S Lab

Sbarro Health Research Organization researcher Dr. Letizia Cito of the CROM Institute, Mercogliano (AV, Italy) delivered a virtual lecture on "Cancer, Cell Cycle, and Check Points" as an invited guest to a scientific meeting sponsored by the University of Barcelona, Spain. Dr. Cito's lecture took place on The Learning Experience Main Campus in Second Life. View the lectures: Part-1 Part-2

Discovery of Small Molecule Leads to New Hope for HIV Therapy

New hope for combating HIV, the virus that leads to AIDS. The Laboratory of Pharmaceutical Chemistry, University of Siena, led by Professor Maurizio Botta, an Adjunct Professor at SHRO, took part to this research.

Nature Clinical Practice Cardiovascular Medicine: September, 2008, Vol.8, No.9

Stem cell niches as clinical targets: the future of anti-ischemic therapy? Editorial on possible clinical impact of research  conducted by an international collaboration of  scientists directed by Sbarro Institute Professor Claudio Napoli, M.D., Ph.D.

Sbarro Institute Professor Claudio Napoli, M.D., Ph.D. Directs International Collaboration on Therapeutic Targeting of the Stem Cell Niche in Experimental Hindlimb Ischemia published in Nature Clinical Practice Cardiovascular Medicine

CNN I-Report Blog: August 14, 2008

Report on tour of  Biomedical Research Labs Island in the company of Prof. Giuseppe Russo (sl name Alfa Roux) , the owner of the sim and CEO of Digi S Lab

SHRO Scores on Second Life: Linden Labs Cites SHRO Platform as Model for Other Health and Wellness Nonprofit Organizations

NewsWise| CNN Blog: Jan 11, 2008

SHRO Opens Internet Center on Futuristic Second Life


SHRO Release: October 21, 2008

Developmental Biologist Gianfranco Bellipanni, Ph.D. Joins  Faculty of the Sbarro Intstitute.


International Team Reveals First Prognosticator of Survival in Aggressive Cancer

Summer Science at Sbarro Institute:  International program mentors college and high school students for 15th year

Anna Rita Fioroni, Senator of the Democratic Party (PD) in Italy, recently paid a visit to the Sbarro Health Research Organization (SHRO) in Philadelphia

SHRO Release
SHRO Fellow Mario Federico, M.D., publishes chapter on brachytherapy in Principles and Practice of Radiation Oncology, the most widely used textbook on radiation oncology.

SHRO Release | NewsWise: June 25, 2008

Protein Cdk9-55 May Induce Muscle Regeneration in Damaged and Healthy Tissues

Journal of Cellular Physiology: June 10, 2008

Cdk9-55: A New Player in Muscle Regeneration

SHRO Release: Mar 20, 2008

Professor Claudio Napoli: Novel Approach May Spell Safer Gene Therapy

SHRO Release: Jan 11, 2008
The Sbarro Health Research Organization, a nonprofit research group, will open its Internet headquarters on Second Life.


SHRO Announcement: Nov 12, 2007
"Langfitt International Fellowships" Established with Funds from the Robert R. Bellamy Memorial Foundation and the Thomas and Carolyn Langfitt Family Foundation.

SHRO Photo Release: July 7, 2007
Antonio Giordano Appears on Comcast Newsmakers to Discuss Cancer Research and Expanding Biotech Sciences in the Philadelphia Region.

SHRO Photo Release: May 18, 2007
Pennsylvania House Speaker John Perzel and Committee Chairman Mario Civera, Jr. Join Ceremony for the new Translational Drug.

SHRO Release: May 15, 2007
Cristina Giacinti, MD, Ph.D., wins the "Borsa Monroy" Fellowship to attend "Embryology: Concepts and Techniques in Modern Developmental Biology" at the Marine Biological Laboratory (MBL) in Woods Hole, MA.

SHRO Release: Feb 28, 2007
Laszlo Otvos, M.D., Ph.D., M.B.A., Director of drug development for Sbarro Institute, publishes one of the "Most Cited Articles: 2006."

SHRO Release: Feb 21, 2007
SHRO joins Roche Diagnostics in an on-site agreement that will provide supplies to researchers at SHRO labs.

SHRO Release: Feb 8, 2007
SHRO Labs Ranked Near Top in Research Publications by the Cell Cycle Lab Registry.

SHRO Announcement: Feb 5, 2007
Antonio Giordano receives the 2007 Saint Valentine Prize in Terni, Italy.

SHRO Announcement: Jan 1, 2007
SHRO Announces Competition for Summer Fellowship in Cancer Research in Siena, Italy.


SHRO Exhibit Announcement: Oct 17, 2006
Sbarro Health Research Organization and Human Health Foundation Exhibit at COM-PA, Milan 21-23 October 2008 (The European Exhibition of Public Communication and Services to Citizen and Business)

SHRO Press Release: Sept 4, 2006
SHRO President Donates Funds to Aid Casa di Riposo Italiana in Uruguay.

SHRO Photo Release: Sept 3, 2006
Fundraiser for SHRO at Positano Coast Restaurant honors Vicent Papale, former Eagles football player and inspiration for hit movie 'Invincible'.

SHRO Release: June 6, 2006
Congressman John Murtha joins officials of Temple's Sbarro Health Research Organization and Windber Research Institute to Announce Pilot Project in Breast Cancer Research.

SHRO Release: April 7, 2006
Sbarro Health Institute and Temple University partner with Italian Trade Commission at BIO 2006 to celebrate renaissance of Italian biotechnology.

SHRO Release: Jan 18, 2007
Eva Surmacz awarded W.W. Smith Grant to examine link between Breast Cancer and Obesity.


SHRO Announcement: Nov 15, 2005
The Real Deal: Funding Strategies for Early Stage Biotechnology Companies: SHRO co-sponsors a half-day conference on the funding environment for the biotechnology industry."

SHRO Photo Release: Oct 15, 2005
La Famiglia Ristorante Hosts Fundraiser for Sbarro Health Research Organization.

SHRO Release: Jul 14, 2005
Epigenetic activity silences Rb2/p130 gene in lung cancer and retinoblastoma cells "Simple test could be developed to determine cancerous or pre-cancerous conditions".

SHRO Announcement: June 9, 2005
The National Organization of Italian Women honors Dr. Antonio Giordano: "The NOIAW presented a Special Recognition Award to Antonio Giordano, M.D., Ph.D., the Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University."


TOP   |    CONTACT   |    SALUTE-PRESS   |    DONATE   |    LINKS

© Copyright 2003 - 2010, Sbarro Health Research Organization,All rights reserved.

download film. video game